NBIXNeurocrine Biosciences, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic

Current Price: $131.60 (+0.00% today)

Market Cap: $13.21B

P/E (TTM): 27.40

Forward P/E (FY1): 22.30

EPS Growth: 30.1%

Analyst Upside: 31.9%

Relative Strength (RS%): 1

-17.8% from 52-week high

Back to Scanner

NBIX

NASDAQRS 1Score 37

Neurocrine Biosciences, Inc.

HealthcareDrug Manufacturers - Specialty & Generic$13.21B3 setups passing
$131.60
0.0% ($0.00)
-17.8% from 52W High
P/E (TTM)
27.40
Fwd P/E
22.30
PEG
0.84
Analyst Upside
+31.9%
EPS Growth
30.1%
Gross Margin
98.2%
ROE
16.7%
D/E
0.13
Div Yield
0.0%
Avg Volume
707.0K

Price Chart

Key Levels

SMA 200
$137.17
SMA 50
$132.00
Price
$131.60
52W High
$160.10
Target
$173.58

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst